Herbalife's Shares Surge 7.2% on Beta Launch of Pro2col Platform
PorAinvest
martes, 19 de agosto de 2025, 3:49 pm ET1 min de lectura
HLF--
The Pro2col platform collects detailed user data, including nutritional goals and sleep quality, to suggest targeted products and improve customer retention. Herbalife plans a full commercial release in the U.S. and Puerto Rico during the fourth quarter of 2025, with further international expansion planned for 2026 [1].
The company's shares, which are known for their volatility, saw a significant rise on this news. However, the market considers this development meaningful but not a fundamental change to its perception of the business [1]. Herbalife is up 43.1% year-to-date (YTD) but is currently trading 11.7% below its 52-week high of $10.83 [1].
In the second quarter of 2025, Herbalife reported net sales of $1.3 billion, a 1.7% year-over-year (YoY) decline, and adjusted EBITDA of $173.6 million, which exceeded guidance. The company increased its full-year 2025 net sales and adjusted EBITDA outlook while lowering capital expenditure (Capex) forecasts [2].
Mizuho lifted its price target on HLF from $8 to $9, maintaining a 'Neutral' rating, reflecting the company's ability to deliver solid results and raise guidance. However, the analyst acknowledged the challenges posed by foreign currency headwinds and the competitive landscape in the health and wellness sector [2].
Investors will have the opportunity to hear directly from Herbalife CEO Stephan Gratziani and CFO John DeSimone at the Barclays Global Consumer Staples Conference on September 2, 2025 [3].
References:
[1] https://www.tradingview.com/news/stockstory:041e6fa0a094b:0-herbalife-hlf-shares-skyrocket-what-you-need-to-know/
[2] https://www.morningstar.com/news/business-wire/20250819248772/herbalife-ceo-and-cfo-to-participate-in-barclays-global-consumer-staples-conference-on-september-2
[3] https://www.ainvest.com/news/herbalife-reports-q2-2025-results-raises-earnings-outlook-mizuho-lifts-pt-9-2508/
Herbalife (HLF) shares jumped 7.2% after the company shared positive preliminary results from the beta launch of its new Pro2col digital health and wellness platform. The platform has seen strong engagement, with over 7,000 distributors participating since July. Herbalife plans a full commercial release in Q4 2025 and international expansion in 2026. The company's shares are volatile, but this news is considered meaningful. Herbalife is up 43.1% YTD but trading 11.7% below its 52-week high.
Herbalife (HLF) shares experienced a 7.2% increase in the morning session following the company's announcement of positive preliminary results from the beta launch of its new Pro2col digital health and wellness platform. The platform, acquired in March, has shown strong engagement, with over 7,000 distributors participating since July [1].The Pro2col platform collects detailed user data, including nutritional goals and sleep quality, to suggest targeted products and improve customer retention. Herbalife plans a full commercial release in the U.S. and Puerto Rico during the fourth quarter of 2025, with further international expansion planned for 2026 [1].
The company's shares, which are known for their volatility, saw a significant rise on this news. However, the market considers this development meaningful but not a fundamental change to its perception of the business [1]. Herbalife is up 43.1% year-to-date (YTD) but is currently trading 11.7% below its 52-week high of $10.83 [1].
In the second quarter of 2025, Herbalife reported net sales of $1.3 billion, a 1.7% year-over-year (YoY) decline, and adjusted EBITDA of $173.6 million, which exceeded guidance. The company increased its full-year 2025 net sales and adjusted EBITDA outlook while lowering capital expenditure (Capex) forecasts [2].
Mizuho lifted its price target on HLF from $8 to $9, maintaining a 'Neutral' rating, reflecting the company's ability to deliver solid results and raise guidance. However, the analyst acknowledged the challenges posed by foreign currency headwinds and the competitive landscape in the health and wellness sector [2].
Investors will have the opportunity to hear directly from Herbalife CEO Stephan Gratziani and CFO John DeSimone at the Barclays Global Consumer Staples Conference on September 2, 2025 [3].
References:
[1] https://www.tradingview.com/news/stockstory:041e6fa0a094b:0-herbalife-hlf-shares-skyrocket-what-you-need-to-know/
[2] https://www.morningstar.com/news/business-wire/20250819248772/herbalife-ceo-and-cfo-to-participate-in-barclays-global-consumer-staples-conference-on-september-2
[3] https://www.ainvest.com/news/herbalife-reports-q2-2025-results-raises-earnings-outlook-mizuho-lifts-pt-9-2508/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios